Inventor · disambiguated record
Thomas Cleveland
Also filed as: CLEVELAND III THOMAS E · CLEVELAND THOMAS · CLEVELAND THOMAS E
33 granted patents·22 pending applications·750 citations·filing 1999–2024
98Inventor score
Top patents by PatentIndex Score
55 records- 0198US10793547B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Oct 6, 2020·24 cites·21 claims
- 0298US9249131B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2014·Granted Feb 2, 2016·50 cites·17 claims
- 0398US8853415B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2013·Granted Oct 7, 2014·67 cites·17 claims
- 0498US8741939B2Modulators of ATP-binding cassette transportersHADIDA RUAH SARA S·Filed 2013·Granted Jun 3, 2014·66 cites·17 claims
- 0598US8431605B2Modulators of ATP-binding cassette transportersHADIDA RUAH SARA S·Filed 2011·Granted Apr 30, 2013·83 cites·16 claims
- 0698US7973169B2Modulators of ATP-Binding Cassette transportersVERTEX PHARMA·Filed 2004·Granted Jul 5, 2011·121 cites·15 claims
- 0797US11591350B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Feb 28, 2023·7 cites·27 claims
- 0897US11584761B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Feb 21, 2023·9 cites·37 claims
- 0997US11453655B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2020·Granted Sep 27, 2022·8 cites·8 claims
- 1097US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 1197US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 1297US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 1397US8410112B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Apr 2, 2013·56 cites·71 claims
- 1496US11873300B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Jan 16, 2024·6 cites·25 claims
- 1596US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 1696US10570115B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Feb 25, 2020·23 cites·18 claims
- 1795US12421251B2Cystic fibrosis transmembrane conductance regulator modulating agentsVERTEX PHARMA·Filed 2020·Granted Sep 23, 2025·5 cites·25 claims
- 1895US11066417B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2019·Granted Jul 20, 2021·13 cites·47 claims
- 1995US8822451B2Modulators of ATP-binding cassette transportersRUAH SARA S HADIDA·Filed 2006·Granted Sep 2, 2014·64 cites·23 claims
- 2094US11866450B2Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·3 cites·41 claims
- 2193US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
- 2293US12122788B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Oct 22, 2024·1 cites·21 claims
- 2392US11186566B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Nov 30, 2021·10 cites·10 claims
- 2491US10738030B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Aug 11, 2020·6 cites·48 claims
- 2588US2025205232A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2685US12319693B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 2781US12384762B2Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 2878US2024368189A1Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the ModulatorsVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2976US6183736B1Small peptides with antipathogenic activity, treated plants and methods for treating sameUSDA ARS SOUTHERN REGIONAL RES·Filed 1999·Granted Feb 6, 2001·37 cites·29 claims
- 3074US2025179091A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 3173US8323706B2Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesisCLEVELAND THOMAS E·Filed 2008·Granted Dec 4, 2012·2 cites·1 claims
- 3272US6703540B1Transformation of plants with a chloroperoxidase gene to enhance disease resistanceUS AGRICULTURE·Filed 2000·Granted Mar 9, 2004·3 cites·35 claims
- 3371US2022306606A1Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3464US12269831B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Apr 8, 2025·0 cites·41 claims
- 3564US2025340574A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3661US2025122218A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3760US8563599B2Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereofERHARDT PAUL W·Filed 2009·Granted Oct 22, 2013·1 cites·10 claims
- 3859US2016228414A1Modulators of atp-binding cassette transportersVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 3958US2013041022A1Glyceollins Suppress Androgen-Responsive Prostate CancerUS AGRICULTURE·Filed 2009·Application pending·0 cites
- 4056US12324802B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Jun 10, 2025·0 cites·53 claims
- 4156US2023382924A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4256US2023416275A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4356US2023373974A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4456US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4556US2023373939A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4656US2023373935A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4756US2023365587A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4856US2024018161A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4956US2023374038A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 5056US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas Cleveland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →